Lysine 68 Methylation‐Dependent SOX9 Stability Control Modulates Chondrogenic Differentiation in Dental Pulp Stem Cells

Qiannan Sun,Zimeng Zhuang,Rushui Bai,Jie Deng,Tianyi Xin,Yunfan Zhang,Qian Li,Bing Han

DOI: https://doi.org/10.1002/advs.202206757

IF: 15.1

2023-06-30

Advanced Science

Abstract:Antantagonistic histone‐modifying enzymes, KDM3A and G9A, bidirectionally regulate chondrogenic differentiation of dental pulp stem cells by altering the ubiquitination of non‐histone SOX9 through demethylation/methylation at K68 residue to control its degradation. Ultimately, KDM3A overexpression or G9A suppression leads to the cumulative activation of SOX9 into a chondrogenic characteristic transcriptional network both in vitro and in vivo. Dental pulp stem cells (DPSCs), characterized by easy availability, multi‐lineage differentiation ability, and high proliferation ability, are ideal seed cells for cartilage tissue engineering. However, the epigenetic mechanism underlying chondrogenesis in DPSCs remains elusive. Herein, it is demonstrated that KDM3A and G9A, an antagonistic pair of histone‐modifying enzymes, bidirectionally regulate the chondrogenic differentiation of DPSCs by controlling SOX9 (sex‐determining region Y‐type high‐mobility group box protein 9) degradation through lysine methylation. Transcriptomics analysis reveals that KDM3A is significantly upregulated during the chondrogenic differentiation of DPSCs. In vitro and in vivo functional analyses further indicate that KDM3A promotes chondrogenesis in DPSCs by boosting the SOX9 protein level, while G9A hinders the chondrogenic differentiation of DPSCs by reducing the SOX9 protein level. Furthermore, mechanistic studies indicate that KDM3A attenuates the ubiquitination of SOX9 by demethylating lysine (K) 68 residue, which in turn enhances SOX9 stability. Reciprocally, G9A facilitates SOX9 degradation by methylating K68 residue to increase the ubiquitination of SOX9. Meanwhile, BIX‐01294 as a highly specific G9A inhibitor significantly induces the chondrogenic differentiation of DPSCs. These findings provide a theoretical basis to ameliorate the clinical use of DPSCs in cartilage tissue‐engineering therapies.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry